These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28339375)

  • 1. Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions.
    Allen LV
    Int J Pharm Compd; 2016; 20(5):399-404. PubMed ID: 28339375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):495-500. PubMed ID: 28339389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations.
    Allen LV
    Int J Pharm Compd; 2017; 21(6):481-486. PubMed ID: 29220338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing.
    Okeke CC; Allen LV
    Int J Pharm Compd; 2009; 11(5):420-6. PubMed ID: 23966526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2010; 14(2):142-9. PubMed ID: 23965426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(3):252-7. PubMed ID: 23969716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(2):136-44. PubMed ID: 23969607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterile ophthalmic ointment and suspension manufacturing.
    Abshire R; Cash P
    J Parenter Sci Technol; 1986; 40(3):97-9. PubMed ID: 3746580
    [No Abstract]   [Full Text] [Related]  

  • 10. Basics of compounding: United States pharmacapeia general chapter 797 pharmaceutical compounding-sterile preparations, part 10: first revision: the main changes, events, and rationale.
    Okeke CC; Newton DW; Kastango ES; Allen LV
    Int J Pharm Compd; 2008; 12(6):530-6. PubMed ID: 23969931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(4):313-23. PubMed ID: 23974791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an erythromycin ophthalmic ointment: putting the puzzle pieces together.
    McElhiney LF
    Int J Pharm Compd; 2010; 14(4):270-4. PubMed ID: 23965533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basics of compounding for the implementation of United States pharmaceopeia chapter 797 pharmaceutical compounding-sterile preparations, part 1.
    Allen LV; Okeke C
    Int J Pharm Compd; 2007; 11(3):230-6. PubMed ID: 23996026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 11.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2009; 13(1):56-62. PubMed ID: 23969965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2009; 13(2):146-50. PubMed ID: 23970008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basics of sterile compounding: compounding by weight versus compounding by volume.
    Thoma L
    Int J Pharm Compd; 2014; 18(2):131-4. PubMed ID: 24881117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A history of the development of eye drops used to treat glaucoma].
    Komatsu Y
    Yakushigaku Zasshi; 2007; 42(1):7-16. PubMed ID: 18175440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraocular penetration of collyria].
    Offret G; Dhermy P
    J Fr Ophtalmol; 1986; 9(5):353-9. PubMed ID: 3543097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(5):440-3. PubMed ID: 23969870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.